Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Aileron Therapeutics Inc.
DescriptionStapled peptide reactivator of the wild type p53 tumor suppressor protein
Molecular Target Mdm2 p53 binding protein homolog (MDM2) (HDM2) ; Mdm4 p53 binding protein homolog (MDM4) (MDMX)
Mechanism of Action 
Therapeutic ModalityPeptide

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today